Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4; no changes to study details or navigation are visible in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T07:47:18.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The Locations section was expanded with many new sites across the US and other countries, and older location blocks were removed; the revision tag was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T19:51:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    PubMed publications note updated to indicate that publications are automatically filled from PubMed. The page revision tag updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-26T13:51:27.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Removed a boilerplate notice about government funding and NIH operating status. The rest of the page content remains focused on the study details.
    Difference
    0.1%
    Check dated 2025-11-19T08:34:32.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Hamburg locations were added and formatted as Hamburg, Hamburg, Germany, replacing the previous 'City state of Hamburg' designation. The PYNNACLE study protocol reference was updated to a newer Future Oncol article.
    Difference
    0.1%
    Check dated 2025-11-12T00:28:32.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Location count updated to 75 locations (replacing 82), enrollment target listed as 300, and timelines updated to primary completion 2026-08-15 and study completion 2027-12-31. New investigators added and eligibility/exclusion criteria as well as Phase 1/2 dosing and combination therapy details updated.
    Difference
    1%
    Check dated 2025-11-04T12:03:28.000Z thumbnail image

Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.